Home › NDC Lookup › RxCUI directory › RxCUI 2714192

Dihydroergotamine 5.2 MG Nasal Powder [Atzumi] — RxCUI 2714192

RxNorm drug concept · Semantic branded drug
RxCUI 2714192 Semantic branded drug · SBD ● Current RxNorm concept 1 FDA product 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2714192
Official nameDihydroergotamine 5.2 MG Nasal Powder [Atzumi]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asAtzumi 5.2 MG Nasal Powder; DHE 5.2 MG Nasal Powder [Atzumi]
FDA products mapped1
Package NDCs mapped2
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Dihydroergotamine Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It stops migraine attacks and cluster headaches in adults once they start. It is not for preventing attacks. Brekiya also isn't for hemiplegic migraine or migraine with brainstem a...
  • It is a prefilled autoinjector that goes under the skin of your middle thigh. Rotate sites and use it only if the liquid is clear and colorless. Stay within the daily and weekly li...
  • Some people get dizziness, headache, flushing, diarrhea, rash, sweating, anxiety, or tingling. Call right away for chest pain, stroke symptoms, or cold, pale, or numb fingers or to...
  • Strong CYP3A4 inhibitors are off limits. These include certain HIV medicines and antibiotics such as clarithromycin and erythromycin, and antifungals like ketoconazole. Also avoid...
📖 Read our full Dihydroergotamine Injection guide →

🕸️ Concept Web — How Dihydroergotamine 5.2 MG Nasal Powder [Atzumi] Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Dihydroergotamine 5.2 MG Nasal Powder [Atzumi] RxCUI 2714192

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Dihydroergotamine 3418
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Atzumi 2714188
  3. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Dihydroergotamine Nasal Powder 2714186
    • Dihydroergotamine Nasal Product 1151869
    • Dihydroergotamine Nasal Powder [Atzumi] 2714191
    • Atzumi Nasal Product 2714190
    • Nasal Powder 1739329
    • Nasal Product 1151130
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Dihydroergotamine 5.2 MG Nasal Powder SCD · 2714187
  • Dihydroergotamine 5.2 MG SCDC · 2714185
  • Dihydroergotamine Nasal Powder SCDF · 2714186
  • Dihydroergotamine Nasal Product SCDG · 1151869

Brand-Name Concepts

  • Dihydroergotamine 5.2 MG [Atzumi] SBDC · 2714189
  • Dihydroergotamine Nasal Powder [Atzumi] SBDF · 2714191
  • Atzumi Nasal Product SBDG · 2714190
  • Atzumi BN · 2714188

📦 FDA Products & Package NDCs

1 product · 2 package NDCs
2 package NDCs map to RxCUI 2714192 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
76978-0101-08 8 BOTTLE, UNIT-DOSE in 1 CARTON (76978-101-08) / 1 POWDER i... ATZUMI Satsuma Pharmaceuticals, Inc. 2025-04-30
76978-0101-11 1 BOTTLE, UNIT-DOSE in 1 CARTON (76978-101-11) / 1 POWDER i... ATZUMI Satsuma Pharmaceuticals, Inc. 2025-04-30
Observed labelers: Satsuma Pharmaceuticals, Inc. (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.